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Background: Recent studies have demonstrated the ability of cardiac magnetic resonance imaging (CMR) to identify the anatomic correlate of 
high grade ventricular arrhythmia (VA) in HCM and coronary heart disease. Little is known about the value of CMR in VA patients without previously 
known cardiac conditions. Thus, we investigated the value of CMR for detection of underlying heart disease/the arrhythmogenic substrate in patients 
with VA.
Methods: VA patients without known cardiac condition were included (n=71). CMR, echo and 12-lead ECGs were performed. CMR findings were 
correlated with ECG and/or electrophysiologic testing (EPS). A morphological substrate was defined as underlying cardiac condition detected by 
CMR, known to cause arrhythmia, or presence of an electro-anatomic correlate, if the location of a structural abnormality/scar tissue, matched the 
origin of the VA (ECG and/or EPS). A positive CMR finding was defined as clinically relevant if the finding resulted in a new diagnosis, or a change of 
treatment, or additional diagnostic procedure.
Results: Pathological CMR findings were found in 42 (59%) patients: e.g. wall motion abnormalities (31%), dilatation (39.4%), myocardial scar/
structural abnormalities (18.3%), hypertrophy (14.1%), pericardial/pleural effusion (8.5%), wall thinning (4.2%). Based on CMR a diagnosis of 
heart disease was established in 19 patients (27%; DCM n=3, HCM n=1, criteria for ARVC n=2, post-myocarditis scar n=7, post-infarction scar n=2, 
myocarditis n=4). All were classified as morphological substrates. In 15 patients (21%) the definite diagnosis was obtained by CMR exclusively. In 8 
patients the location of the relevant CMR finding (myocardial scar) directly matched the origin of the VA. The diagnoses led to a change of treatment 
in 11 patients and change of treatment plus additional diagnostic procedure in 8 patients.
Conclusions: This is the first study revealing the value of CMR for detection of the morphological substrate/ underlying cardiac condition in VA 
patients without previously known cardiac disease. The high incidence of clinically relevant CMR findings raises the question, whether CMR should 
routinely be performed in those patients.
